RHO and hepatocellular carcinoma: BMP9 overexpression in HBV‐infected HCC cells could promote intra‐tumoural infiltration of cytotoxic lymphocytes via vascular normalisation by inhibiting the Rho‐ROCK‐MLC pathway, resulting in enhanced anti‐PD‐L1 immunotherapy.